HCC risk in PSC (Hepatology Jan. 26)

Introduction:

Primary sclerosing cholangitis (PSC) is a chronic liver disease that can lead to complications, including hepatocellular carcinoma (HCC). However, the actual risk of developing HCC in PSC patients has been unclear, leading to questions about the necessity of current HCC surveillance guidelines.

Problem Statement:

A study involving 3071 PSC patients across 12 university hospitals was conducted to better understand the risk of HCC. Patients were followed for an average total of 38,387 person-years, from PSC diagnosis until death, liver transplantation, or other significant events. The study aimed to identify factors associated with HCC development, such as age and cirrhosis status, to refine surveillance strategies.

Conclusion:

The study found that HCC is relatively rare in PSC patients, especially in those without cirrhosis and under the age of 50. Cirrhosis was a significant risk factor for HCC, with most cases occurring in cirrhotic patients. Age also increased the risk, but for non-cirrhotic patients, the risk remained low across all age groups. These findings suggest that HCC surveillance in PSC patients can be tailored based on individual risk factors like age and cirrhosis status, potentially reducing unnecessary monitoring in low-risk groups.